Management guides for FQ4 revenue of $598.7M-$622.2M (+2%-6% sequentially) vs. analyst expectations ranging from $610M-$632M (average of $621.1M). Opex in FQ4 is seen at $226M.
Revenue from 28nm products hit $100M during the quarter, driven by sales of Kintex-7 and the Zynq-7000 family (which more than doubled sequentially).
Expansion in Asia-Pacific led the way, contributing 40% of revenue in FQ3 (up from 34% in FQ3 FY2013).
PR, Conference call at 5pm ET
Shares of Altera (ALTR) are off 0.6% AH in sympathy.